
© 2024 ARIVA.de
Realtime | Geld | Brief | Zeit |
---|---|---|---|
109,00 | 109,20 | 22:53 | |
108,80 | 109,50 | 22:00 |
Zeit | Aktuelle Nachrichten | |
---|---|---|
Fr | Vertex, Alnylam Best Positioned As Biopharma Braces For Tariff Impact, Goldman Sachs Flags Regeneron, Biogen Risks | |
Fr | Biogen downgraded to Hold at Argus on profit decline expectations | |
Do | BIIB's Experimental Alzheimer's Drug Gets FDA Fast Track Tag | |
Do | RBC Capital cuts Biogen stock price target to $221 | |
Do | FDA grants fast track status to Biogen's BIIB080 for Alzheimer's |